{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:39:46Z","timestamp":1785886786825,"version":"3.56.0"},"reference-count":31,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T00:00:00Z","timestamp":1486080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471597"],"award-info":[{"award-number":["81471597"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671612"],"award-info":[{"award-number":["81671612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601427"],"award-info":[{"award-number":["81601427"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013286","name":"Specialized Research Fund for the Doctoral Program of Higher Education","doi-asserted-by":"crossref","award":["20130171110075"],"award-info":[{"award-number":["20130171110075"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2016A030313307"],"award-info":[{"award-number":["2016A030313307"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2014A030313074"],"award-info":[{"award-number":["2014A030313074"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Rheum Dis"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1111\/1756-185x.13010","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T20:52:03Z","timestamp":1486155123000},"page":"859-869","source":"Crossref","is-referenced-by-count":92,"title":["Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation"],"prefix":"10.1111","volume":"20","author":[{"given":"Le-Feng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Rheumatology; Sun Yat-Sen Memorial Hospital; Sun Yat-Sen University; Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Qian","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology; Sun Yat-Sen Memorial Hospital; Sun Yat-Sen University; Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Rheumatology; Sun Yat-Sen Memorial Hospital; Sun Yat-Sen University; Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Da","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology; Sun Yat-Sen Memorial Hospital; Sun Yat-Sen University; Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hui","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology; Sun Yat-Sen Memorial Hospital; Sun Yat-Sen University; Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lie","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology; Sun Yat-Sen Memorial Hospital; Sun Yat-Sen University; Guangzhou China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,3]]},"reference":[{"key":"10.1111\/1756-185X.13010-BIB0001|apl13010-cit-0001","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(75)80054-0","article-title":"Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders","volume":"68","author":"Wands","year":"1975","journal-title":"Gastroenterology"},{"key":"10.1111\/1756-185X.13010-BIB0002|apl13010-cit-0002","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/01.TP.0000151661.52601.FB","article-title":"Progressive disappearance of anti-hepatitis B surface antigen antibody and reverse seroconversion after allogeneic hematopoietic stem cell transplantation in patients with previous hepatitis B virus infection","volume":"79","author":"Onozawa","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/1756-185X.13010-BIB0003|apl13010-cit-0003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1034\/j.1600-0609.2000.9l228.x","article-title":"Reactivation of hepatitis B virus infection in an anti-HBc and anti-HBs positive patient after allogeneic bone marrow transplantation","volume":"65","author":"Nordb\u00f8","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1111\/1756-185X.13010-BIB0004|apl13010-cit-0004","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00277-011-1241-0","article-title":"Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative\/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis","volume":"90","author":"Koo","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1111\/1756-185X.13010-BIB0005|apl13010-cit-0005","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/1756-185X.13010-BIB0006|apl13010-cit-0006","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/1756-185X.13010-BIB0007|apl13010-cit-0007","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"10.1111\/1756-185X.13010-BIB0008|apl13010-cit-0008","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10067-013-2170-1","article-title":"The association between hepatitis B virus infection and disease activity, synovitis, or joint destruction in rheumatoid arthritis","volume":"32","author":"Zou","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1111\/1756-185X.13010-BIB0009|apl13010-cit-0009","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"key":"10.1111\/1756-185X.13010-BIB0010|apl13010-cit-0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/1471-2474-15-449","article-title":"Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice","volume":"15","author":"Mo","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1111\/1756-185X.13010-BIB0011|apl13010-cit-0011","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MD.0b013e3182380a76","article-title":"Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases","volume":"90","author":"P\u00e9rez-Alvarez","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/1756-185X.13010-BIB0012|apl13010-cit-0012","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10067-013-2385-1","article-title":"Anti-TNF therapy in patients with HBV infection-analysis of 87 patients with inflammatory arthritis","volume":"33","author":"Ye","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1111\/1756-185X.13010-BIB0013|apl13010-cit-0013","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1136\/ard.2010.148783","article-title":"Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy","volume":"70","author":"Lan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/1756-185X.13010-BIB0014|apl13010-cit-0014","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3109\/10428194.2014.947606","article-title":"The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative\/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab based chemotherapy","volume":"56","author":"Lu","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/1756-185X.13010-BIB0015|apl13010-cit-0015","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/art.23940","article-title":"Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study","volume":"58","author":"Genovese","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/1756-185X.13010-BIB0016|apl13010-cit-0016","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.2008.105197","article-title":"Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study","volume":"69","author":"Jones","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/1756-185X.13010-BIB0017|apl13010-cit-0017","first-page":"323","article-title":"The efficacy and safety of tocilizumab combined with disease-modifying anti-rheumatoid drugs in the treatment of active rheumatoid arthritis: a multi-center, randomized, double-blinded, placebo-controlled trial","volume":"52","author":"Shi","year":"2013","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"5 Suppl.","key":"10.1111\/1756-185X.13010-BIB0018|apl13010-cit-0018","doi-asserted-by":"crossref","first-page":"S156","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagle","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/1756-185X.13010-BIB0019|apl13010-cit-0019","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.gastro.2014.10.038","article-title":"American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Perrillo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1111\/1756-185X.13010-BIB0020|apl13010-cit-0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrgastro.2013.216","article-title":"Management of patients with hepatitis B who require immunosuppressive therapy","volume":"11","author":"Hwang","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1111\/1756-185X.13010-BIB0021|apl13010-cit-0021","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"Singh","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1111\/1756-185X.13010-BIB0022|apl13010-cit-0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/acr.22783","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1111\/1756-185X.13010-BIB0023|apl13010-cit-0023","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/rheumatology\/ken384","article-title":"Long-term tocilizumab therapy in a patient with rheumatoid arthritis and chronic hepatitis B","volume":"47","author":"Nagashima","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/1756-185X.13010-BIB0024|apl13010-cit-0024","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3109\/s10165-011-0470-3","article-title":"A patient with rheumatoid arthritis treated with tocilizumab together with lamivudine prophylaxis after remission of infliximab reactivated hepatitis B","volume":"21","author":"Tsuboi","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1111\/1756-185X.13010-BIB0025|apl13010-cit-0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/s10165-010-0365-8","article-title":"Successful tocilizumab treatment in a patient with adult-onset Still's disease complicated by chronic active hepatitis B and amyloid A amyloidosis","volume":"21","author":"Kishida","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1111\/1756-185X.13010-BIB0026|apl13010-cit-0026","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Reddy","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1111\/1756-185X.13010-BIB0027|apl13010-cit-0027","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection","volume":"50","author":"H\u00f6sel","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/1756-185X.13010-BIB0028|apl13010-cit-0028","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1423-0127-16-41","article-title":"HBV replication is significantly reduced by IL-6","volume":"16","author":"Kuo","year":"2009","journal-title":"J Biomed Sci"},{"issue":"1","key":"10.1111\/1756-185X.13010-BIB0029|apl13010-cit-0029","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.virol.2006.11.018","article-title":"Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B","volume":"361","author":"Stoop","year":"2007","journal-title":"Virology"},{"key":"10.1111\/1756-185X.13010-BIB0030|apl13010-cit-0030","doi-asserted-by":"crossref","first-page":"R179","DOI":"10.1186\/ar2868","article-title":"Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients","volume":"11","author":"Charpin","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/1756-185X.13010-BIB0031|apl13010-cit-0031","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/annrheumdis-2012-202088","article-title":"Long-term safety of rituximab in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection","volume":"72","author":"Mitroulis","year":"2013","journal-title":"Ann Rheum Dis"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.13010","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/1756-185X.13010\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T14:19:51Z","timestamp":1625494791000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.13010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,3]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1111\/1756-185x.13010","archive":["Portico"],"relation":{},"ISSN":["1756-1841"],"issn-type":[{"value":"1756-1841","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2,3]]}}}